Spanish Meaning-Centered Psychotherapy for Cancer

NCT05197348 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2023-05-17

No results posted yet for this study

Summary

The aim of this study is to verify the efficacy of the Spanish adaptation of Meaning-Centered Psychotherapy for Spanish participants with cancer in a randomized control trial.

Conditions

Interventions

BEHAVIORAL

Meaning-Centered Group Psychotherapy (MCP).

The MCP program is divided into eight sessions: Session1: Psychoeducation about Meaning in life, Sources of Meaning, etc. Session 2: Cancer illness and meaning. Session 3: Historical Sources of Meaning (the past) Session 4: Historical Sources of Meaning (present and future). Session 5: Attitudinal Sources of Meaning. Session 6: Creative Sources of Meaning. Session 7: Experimental Sources of Meaning. Session 8: End of psychotherapy, farewell, and facing the future with hope.

BEHAVIORAL

Cognitive Behavioral Psychotherapy (CBT).

The CBT divided into eight sessions: Session1: Presentation of psychotherapy, establishing the goals of psychotherapy. Presentation of the participants. Updated information about psychological consequences of cancer. Session 2. Increase in enjoyable activities. Behavioral activation. Progressive muscle relaxation training. Slow breathing training. Session 3. Cognitive model of coping with cancer. Psychoeducation on negative thoughts. Training in detecting negative thoughts. Presentation of cognitive distortions Session 4. Training in cognitive restructuring techniques. Session 5. Training in problem-solving skills. Session 6. Being aware of participants needs. Self-care. Assertiveness skills training. Session 7. Setting goals for the future. Session 8. Summary, relapse prevention, and end of psychotherapy.

Sponsors & Collaborators

  • University of Valencia

    lead OTHER

Principal Investigators

  • Pilar Llombart, Ph.D.Student · Valencian Institute of Oncology Foundation (IVO)

  • Sandra Perez, Ph.D. · University of Valencia

  • Veronica Guillen Botella, Ph.D. · University of Valencia

  • Joaquin Garcia-Alandete, Ph.D. · University of Valencia

  • Rosa Baños, Ph.D. · University of Valencia

  • Jose Heliodoro Marco Salvador, Ph. D. · University of Valencia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-02
Primary Completion
2023-04-01
Completion
2023-04-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05197348 on ClinicalTrials.gov